Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

CUSIP: 59935V107

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
+19,359
Put/Call ratio
22%
SEC-reported price per share
$1.94
Number of holders
43
Value change
+$893,027
Number of buys
19
Open additional details 1 more signal available
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
124,817,707

Security key

59935V107

Report period

Q2 2025

Institutions

43

Top holders

10

Ownership snapshot

Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTEGRATED CORE STRATEGIE...
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 3/4/5 13F Lead comparable stake: 0.6% 13D/G row: INTEGRATED CORE STRATEGIES (US) LLC Showing 1-6 of 15 holder rows.

Quick read

INTEGRATED CORE STRATEGIES (US) LLC leads the comparable SEC ownership view at 0.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTEGRATED CORE STRATEGIES (US) LLC's linked filing trail.
Comparable ownership Top 5
INTEGRATED CORE STRATEGIES (US) LLC 0.6%
RTW INVESTMENTS, LP 2%
Propel Bio Management, LLC 1.2%
Alta Fundamental Advisers LLC 1.1%
BML Capital Management, LLC 0.91%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
0.6%
$396,161
322,082 shares
$0 31 Mar 2025
RTW INVESTMENTS, LP
3/4/5 13F
10%+ Owner · Company
2%
from 13F
$28,360,648
3,256,102 shares
22 Mar 2023
Propel Bio Management, LLC
13F
Company
13F
1.2%
$1,161,391
1,451,557 shares
31 Mar 2025
Alta Fundamental Advisers LLC
13F
Company
13F
1.1%
$1,142,126
1,427,479 shares
31 Mar 2025
BML Capital Management, LLC
13F
Company
13F
0.91%
$908,986
1,136,091 shares
31 Mar 2025
MORGAN STANLEY
13F
Company
13F
0.78%
$774,917
968,525 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
11,817,806
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
43
Q2 2025 holders
43
Holder diff
0
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .